GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
194 hedge funds and large institutions have $2.18B invested in Global Blood Therapeutics, Inc. in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 77 increasing their positions, 65 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
14% less call options, than puts
Call options by funds: $13.8M | Put options by funds: $16M
21% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 34
Holders
194
Holding in Top 10
10
Calls
$13.8M
Puts
$16M
Top Buyers
| 1 | +$42.9M | |
| 2 | +$30.9M | |
| 3 | +$30.3M | |
| 4 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$27.5M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$25.7M |
Top Sellers
| 1 | -$47.1M | |
| 2 | -$43.3M | |
| 3 | -$37.1M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$35.9M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$32.3M |